Authors: Kantarjian, HM Talpaz, M Santini, V Murgo, A Cheson, B O'Brien, SM

Citation: Hm. Kantarjian et al., Homoharringtonine - History, current research, and future directions, CANCER, 92(6), 2001, pp. 1591-1605

Authors: Kantarjian, HM Talpaz, M Smith, TL Cortes, J Giles, FJ Rios, MB Mallard, S Gajewski, A Murgo, A Cheson, B O'Brien, S

Citation: Hm. Kantarjian et al., Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemia, J CL ONCOL, 18(20), 2000, pp. 3513-3521

Authors: Flinn, IW Kopecky, KJ Foucar, MK Head, D Bennett, JM Huchison, R Corbett, W Cassileth, P Habermann, T Golomb, H Rai, K Eisenhauer, E Appelbaum, F Cheson, B Grever, MR

Citation: Iw. Flinn et al., Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin, BLOOD, 96(9), 2000, pp. 2981-2986

Authors: Vey, N Kantarjian, H Tran, H Beran, M O'Brien, S Bivins, C Giles, F Cortes, J Cheson, B Arbuck, S Estey, E

Citation: N. Vey et al., Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemia, ANN ONCOL, 10(5), 1999, pp. 577-583

Authors: O'Brien, S Kantarjian, H Koller, C Feldman, E Beran, M Andreeff, M Giralt, S Cheson, B Keating, M Freireich, E Rios, MB Talpaz, M

Citation: S. O'Brien et al., Sequential homoharringtonine and interferon-alpha in the treatment of early chronic phase chronic myelogenous leukemia, BLOOD, 93(12), 1999, pp. 4149-4153

Authors: Barlogie, B Jagannath, S Desikan, KR Mattox, S Vesole, D Siegel, D Tricot, G Munshi, N Fassas, A Singhal, S Mehta, J Anaissie, E Dhodapkar, D Naucke, S Cromer, J Sawyer, J Epstein, J Spoon, D Ayers, D Cheson, B Crowley, J

Citation: B. Barlogie et al., Total therapy with tandem transplants for newly diagnosed multiple myeloma, BLOOD, 93(1), 1999, pp. 55-65